Kumar Amresh
CIK: 0001978220•VP Program Management
Officer
Primary company: Grace Therapeutics, Inc. (GRCE)
Kumar Amresh is a corporate insider (VP Program Management) at Grace Therapeutics, Inc. (GRCE) filing SEC Form 4 transactions. 4 transactions. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 30,000 | - | - | 30,000 | 4/14/2025 Filed: 4/16/2025 | Filing → | |
Acasti Pharma Inc. ACST | Award | 19,740 | - | - | 19,740 | 5/6/2024 Filed: 5/10/2024 | Filing → |
Acasti Pharma Inc. ACST | Award | 19,740 | - | - | 19,740 | 5/6/2024 Filed: 5/8/2024 | Filing → |
Acasti Pharma Inc. ACST | Award | 42,000 | $0.00 | $0 | 42,000 | 7/14/2023 Filed: 7/18/2023 | Filing → |
Type
Award
Shares
30,000
Price
-
Value
-
Acasti Pharma Inc.
ACST
Type
Award
Shares
19,740
Price
-
Value
-
Acasti Pharma Inc.
ACST
Type
Award
Shares
19,740
Price
-
Value
-
Acasti Pharma Inc.
ACST
Type
Award
Shares
42,000
Price
$0.00
Value
$0
AI Agent
Try asking...